<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mckesson Corporation — News on 6ix</title>
<link>https://6ix.com/company/mckesson-corporation</link>
<description>Latest news and press releases for Mckesson Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mckesson-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835968478dffbe2df1049a0.webp</url>
<title>Mckesson Corporation</title>
<link>https://6ix.com/company/mckesson-corporation</link>
</image>
<item>
<title>McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-signs-agreement-with-apollo-funds-for-strategic-minority-interest-in-medical-surgical-solutions</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-signs-agreement-with-apollo-funds-for-strategic-minority-interest-in-medical-surgical-solutions</guid>
<pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
<description>IRVING, Texas, April 20, 2026--McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo ("Apollo Funds"), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions ("MMS") business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public off</description>
</item>
<item>
<title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-announces-fourth-quarter-fiscal-2026-earnings-release-date-and-participation-in-upcoming-conferences-26</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-announces-fourth-quarter-fiscal-2026-earnings-release-date-and-participation-in-upcoming-conferences-26</guid>
<pubDate>Fri, 06 Mar 2026 13:00:00 GMT</pubDate>
<description>IRVING, Texas, March 06, 2026--McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.</description>
</item>
<item>
<title>McKesson Announces Planned CFO Transition</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-announces-planned-cfo-transition-13</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-announces-planned-cfo-transition-13</guid>
<pubDate>Thu, 05 Mar 2026 13:10:00 GMT</pubDate>
<description>IRVING, Texas, March 05, 2026--McKesson Corporation (NYSE: MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as Executive Vice President and CFO, effective May 29, 2026.</description>
</item>
<item>
<title>McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-211000483</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-211000483</guid>
<pubDate>Wed, 04 Feb 2026 21:10:00 GMT</pubDate>
<description>IRVING, Texas, February 04, 2026--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.</description>
</item>
<item>
<title>McKesson Corporation Completes Divestiture of Norwegian Operations</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-completes-divestiture-norwegian-130000224</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-completes-divestiture-norwegian-130000224</guid>
<pubDate>Fri, 30 Jan 2026 13:00:00 GMT</pubDate>
<description>IRVING, Texas, January 30, 2026--McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group.</description>
</item>
<item>
<title>McKesson Corporation Declares Quarterly Dividend</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-declares-quarterly-dividend-130000708</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-declares-quarterly-dividend-130000708</guid>
<pubDate>Wed, 28 Jan 2026 13:00:00 GMT</pubDate>
<description>IRVING, Texas, January 28, 2026--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on April 1, 2026, to shareholders of record on March 2, 2026.</description>
</item>
<item>
<title>McKesson’s Practice Insights Designated as a 2026 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-practice-insights-designated-2026-130000625</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-practice-insights-designated-2026-130000625</guid>
<pubDate>Tue, 20 Jan 2026 13:00:00 GMT</pubDate>
<description>IRVING, Texas, January 20, 2026--For the tenth year, CMS named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based Incentive Payment System.</description>
</item>
<item>
<title>AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies</title>
<link>https://6ix.com/company/mckesson-corporation/news/aop-healths-rapiblyktm-now-accessible-via-leading-us-healthcare-improvement-companies</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/aop-healths-rapiblyktm-now-accessible-via-leading-us-healthcare-improvement-companies</guid>
<pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
<description>John Kimmet General Manager of AOP Health US WILMINGTON, Del., Jan. 12, 2026 (GLOBE NEWSWIRE) -- AOP Health US, LLC announced today that Rapiblyk™ (landiolol) is now more widely available across the United States through Cardinal, Cencora Specialty Distribution, McKesson Corporation, and M&D Specialty Distribution. Hospitals and health systems nationwide can now access Rapiblyk™ through their preferred purchasing channels, enhancing flexibility while expanding the availability of this critical c</description>
</item>
<item>
<title>Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-announces-third-quarter-130000430</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-announces-third-quarter-130000430</guid>
<pubDate>Mon, 22 Dec 2025 13:00:00 GMT</pubDate>
<description>IRVING, Texas, December 22, 2025--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.</description>
</item>
<item>
<title>McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-advancing-community-oncology-report-130000924</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-advancing-community-oncology-report-130000924</guid>
<pubDate>Mon, 01 Dec 2025 13:00:00 GMT</pubDate>
<description>IRVING, Texas, December 01, 2025--McKesson published its first-ever Advancing Community Oncology Report, a look at the trends influencing community oncology practices across the U.S.</description>
</item>
<item>
<title>McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-211000338</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-211000338</guid>
<pubDate>Wed, 05 Nov 2025 21:10:00 GMT</pubDate>
<description>IRVING, Texas, November 05, 2025--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.</description>
</item>
<item>
<title>Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch</title>
<link>https://6ix.com/company/mckesson-corporation/news/citius-oncology-signs-us-distribution-agreement-with-mckesson-to-support-lymphirtm-commercial-launch-1</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/citius-oncology-signs-us-distribution-agreement-with-mckesson-to-support-lymphirtm-commercial-launch-1</guid>
<pubDate>Mon, 20 Oct 2025 12:37:00 GMT</pubDate>
<description>Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced it has entered into a distribution services agreement with McKesson Corporation (NYSE: MCK), one of the largest pharmaceutical distributors and healthcare services companies in North America. Under the agreement, McKesson will serve as an authorized distributor of record for LYMPHIR (denileukin diftitox-cxdl), a novel immunoth</description>
</item>
<item>
<title>Cell and Gene Therapies on the Rise: New Report Reveals Growing Adoption and Persistent Challenges</title>
<link>https://6ix.com/company/mckesson-corporation/news/cell-and-gene-therapies-on-the-rise-new-report-reveals-growing-adoption-and-persistent-challenges</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/cell-and-gene-therapies-on-the-rise-new-report-reveals-growing-adoption-and-persistent-challenges</guid>
<pubDate>Mon, 06 Oct 2025 11:00:00 GMT</pubDate>
<description>IRVING, Texas, October 06, 2025--InspiroGene™ by McKesson today announced the publication of its second annual 2025 Cell and Gene Therapy Report: Advancing the Future of Medicine.</description>
</item>
<item>
<title>McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-highlights-strategic-growth-120000981</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-highlights-strategic-growth-120000981</guid>
<pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate>
<description>IRVING, Texas, September 23, 2025--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company’s multi-year strategic priorities, growth strategies, and long-term business outlook.</description>
</item>
<item>
<title>McKesson Announces New Organizational Structure</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-announces-organizational-structure-120000705</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-announces-organizational-structure-120000705</guid>
<pubDate>Thu, 18 Sep 2025 12:00:00 GMT</pubDate>
<description>IRVING, Texas, September 18, 2025--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders.</description>
</item>
<item>
<title>Playhouse MD™ Launches on Amazon with McKesson Medical-Surgical Leading Distribution of First-Ever Playful Pediatric Devices</title>
<link>https://6ix.com/company/mckesson-corporation/news/playhouse-mdtm-launches-on-amazon-with-mckesson-medical-surgical-leading-distribution-of-first-ever-playful-pediatric-devices</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/playhouse-mdtm-launches-on-amazon-with-mckesson-medical-surgical-leading-distribution-of-first-ever-playful-pediatric-devices</guid>
<pubDate>Tue, 09 Sep 2025 12:28:00 GMT</pubDate>
<description>Playhouse MD™, the new healthcare brand dedicated to reimagining pediatric care through the power of play, is now officially available on Amazon.</description>
</item>
<item>
<title>USAntibiotics Working with Walmart and McKesson to Support U.S. Manufacturing of Amoxicillin</title>
<link>https://6ix.com/company/mckesson-corporation/news/usantibiotics-working-with-walmart-and-mckesson-to-support-us-manufacturing-of-amoxicillin</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/usantibiotics-working-with-walmart-and-mckesson-to-support-us-manufacturing-of-amoxicillin</guid>
<pubDate>Mon, 08 Sep 2025 13:00:00 GMT</pubDate>
<description>BRISTOL, Tenn., September 08, 2025--USAntibiotics, the nation’s lone remaining manufacturer of amoxicillin and amoxicillin clavulanate, today announced a new collaboration with Walmart and McKesson through their joint venture partner ClarusONE Sourcing Services to provide domestically manufactured antibiotics made by USAntibiotics in the United States for millions of patients nationwide.</description>
</item>
<item>
<title>Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies</title>
<link>https://6ix.com/company/mckesson-corporation/news/pharmacy-profiles-to-provide-credential-verification-services-for-mckessons-health-mart-pharmacies</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/pharmacy-profiles-to-provide-credential-verification-services-for-mckessons-health-mart-pharmacies</guid>
<pubDate>Fri, 08 Aug 2025 18:53:00 GMT</pubDate>
<description>Pharmacy Profiles, the trusted source for pharmacist identity and credentialing services, today announced a new agreement with McKesson Corporation to provide credential verification services for McKesson's Health Mart independent pharmacy network.</description>
</item>
<item>
<title>McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-201000909</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-reports-fiscal-2026-201000909</guid>
<pubDate>Wed, 06 Aug 2025 20:10:00 GMT</pubDate>
<description>IRVING, Texas, August 06, 2025--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.</description>
</item>
<item>
<title>McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share</title>
<link>https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-raises-quarterly-dividend-120000440</link>
<guid isPermaLink="true">https://6ix.com/company/mckesson-corporation/news/mckesson-corporation-raises-quarterly-dividend-120000440</guid>
<pubDate>Wed, 30 Jul 2025 12:00:00 GMT</pubDate>
<description>IRVING, Texas, July 30, 2025--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.</description>
</item>
</channel>
</rss>